Key result
Suramin-mediated SLC25A inhibition emerges as a potential therapeutic strategy for diet-induced HFpEF.
Why the study?
It is unclear whether high fat diet and homocystinuria contribute synergistically to HFpEF through epigenetic folate 1-carbon metabolism dysregulation and altered homocysteine transport.
Does SLC25A inhibition via suramin counteract diet-induced epigenetic disruptions contributing to HFpEF?
Does SLC25A inhibition via suramin counteract diet-induced epigenetic disruptions contributing to HFpEF?
This review proposes a novel epigenetic mechanism linking high fat diet and homocystinuria to HFpEF, highlighting SLC25A inhibition by suramin as a potential therapeutic target.
Suramin should not yet enter HFpEF care; leaves open whether SLC25A inhibition counters diet-driven epigenetic and homocysteine pathways.
Heart failure with preserved ejection fraction (HFpEF) is a primary cause in patients with metabolic dysfunction and hypertension. A chronic high fat diet (HFD) creates metabolic dysfunction and dysregulation of epigenetic folate 1-carbon metabolism (FOCM), elevating the homocysteine levels (Hcy, characteristic of homocystinuria or HHcy). Homocystinuria has been associated with an increase in blood pressure (via abrogation eNOS pathways) and hypertension. It is unclear whether HFD and homocystinuria contribute synergistically to HFpEF. The HFD may increase the method of transportation via the SLC25A transporter and dysregulate FOCM, creating homocystinuria. The inhibition of SLC25A by suramin could attenuate the FOCM, DNMT1, and TET2 levels, and cardiac dysfunction during HFD and homocystinuria. Because HFD increases methionine and decreases homocysteine transsulfuration via the SLC7A transporter, we hypothesize that the induction of SLC7A will increase homocysteine transport into the mitochondrial transsulfuration, and will produce H2S during HFD and homocystinuria. The overall hypothesis to be tested is that a HFD increases methionine transport by SLC25A and induces epigenetic FOCM, homocystinuria, and decreases mitochondrial transsulfuration by SLC7A, CBS/CSE/3MST and H2S, causing HFpEF. This review introduces a novel framework to understand how diet-induced epigenetic disruptions contribute to HFpEF through altered homocysteine metabolism and hypertension. Additionally, it explores the therapeutic potential of SLC25A inhibition via suramin to counteract these effects. Insights gained from those studies will underscore the critical role of HFD-induced HFpEF and open pathways for new interventions.
No takes yet. Share an insight, caveat, or question.
Tyagi et al. (2026) conducted a review in Heart failure with preserved ejection fraction (HFpEF). High fat diet (HFD) was evaluated. A high fat diet is hypothesized to induce epigenetic disruptions and homocystinuria, contributing to HFpEF, with SLC25A inhibition via suramin proposed as a potential therapeutic intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: